Literature DB >> 8926043

Comparative effect of C3a and C5a on adhesion molecule expression on neutrophils and endothelial cells.

K E Foreman1, M M Glovsky, R L Warner, S J Horvath, P A Ward.   

Abstract

Complement activation is known to enhance neutrophil binding to human umbilical vein endothelial cells (HUVECs). Recently, we have shown that recombinant human C5a upregulates P-selectin in HUVECs. Unstimulated human neutrophil binding is also increased on C5a stimulated HUVECs. We demonstrate in this report that C5a upregulates CD11b/CD18 in human neutrophils. Also shown is that synthetic C3a57-77 and an analog 15 amino acid C3a peptide (C3a15) neither upregulate CD11b/CD18 nor do the C3a peptides increase P-selectin, ICAM-1 or E-selectin in HUVECs. Thus C5a and not C3a is responsible for early (approximately 30 minutes) neutrophil adhesion to endothelial cells after complement activation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8926043     DOI: 10.1007/bf01487740

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  16 in total

1.  C3a57-77, a C-terminal peptide, causes thromboxane-dependent pulmonary vascular constriction in isolated perfused rat lungs.

Authors:  M L Morganroth; S O Schoeneich; G O Till; P A Ward; S J Horvath; M M Glovsky
Journal:  Am Rev Respir Dis       Date:  1990-02

2.  Rapid induction of neutrophil-endothelial adhesion by endothelial complement fixation.

Authors:  R M Marks; R F Todd; P A Ward
Journal:  Nature       Date:  1989-05-25       Impact factor: 49.962

Review 3.  Anaphylatoxins: C3a and C5a.

Authors:  T E Hugli; H J Müller-Eberhard
Journal:  Adv Immunol       Date:  1978       Impact factor: 3.543

4.  Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis.

Authors:  M A Arnaout; R M Hakim; R F Todd; N Dana; H R Colten
Journal:  N Engl J Med       Date:  1985-02-21       Impact factor: 91.245

5.  Neutrophil-dependent acute lung injury. Requirement for P-selectin (GMP-140).

Authors:  M S Mulligan; M J Polley; R J Bayer; M F Nunn; J C Paulson; P A Ward
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

6.  Roles of beta 2 integrins of rat neutrophils in complement- and oxygen radical-mediated acute inflammatory injury.

Authors:  M S Mulligan; J Varani; J S Warren; G O Till; C W Smith; D C Anderson; R F Todd; P A Ward
Journal:  J Immunol       Date:  1992-03-15       Impact factor: 5.422

7.  Human C5a modulates monocyte Fc and C3 receptor expression.

Authors:  K B Yancey; J O'Shea; T Chused; E Brown; T Takahashi; M M Frank; T J Lawley
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

8.  Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release.

Authors:  M M Glovsky; T E Hugli; T Ishizaka; L M Lichtenstein; B W Erickson
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

9.  Rapid analysis of leukocyte-endothelial adhesion.

Authors:  A A Vaporciyan; M L Jones; P A Ward
Journal:  J Immunol Methods       Date:  1993-02-26       Impact factor: 2.303

10.  C5a-induced expression of P-selectin in endothelial cells.

Authors:  K E Foreman; A A Vaporciyan; B K Bonish; M L Jones; K J Johnson; M M Glovsky; S M Eddy; P A Ward
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

View more
  32 in total

1.  Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor.

Authors:  M S Mulligan; A B Lentsch; M Huber-Lang; R F Guo; V Sarma; C D Wright; T R Ulich; P A Ward
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

Review 2.  The complement cascade as a therapeutic target in intracerebral hemorrhage.

Authors:  Andrew F Ducruet; Brad E Zacharia; Zachary L Hickman; Bartosz T Grobelny; Mason L Yeh; Sergey A Sosunov; E Sander Connolly
Journal:  Exp Neurol       Date:  2009-07-24       Impact factor: 5.330

3.  The intrinsic complement regulator decay-accelerating factor modulates the biological response to vascular injury.

Authors:  Masashi Sakuma; Toshifumi Morooka; Yunmei Wang; Can Shi; Kevin Croce; Huiyun Gao; Michael Strainic; M Edward Medof; Daniel I Simon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-03-18       Impact factor: 8.311

Review 4.  Complement inhibition as a proposed neuroprotective strategy following cardiac arrest.

Authors:  Brad E Zacharia; Zachary L Hickman; Bartosz T Grobelny; Peter A DeRosa; Andrew F Ducruet; E Sander Connolly
Journal:  Mediators Inflamm       Date:  2010-01-26       Impact factor: 4.711

5.  The contribution of mannose binding lectin to reperfusion injury after ischemic stroke.

Authors:  Helena Morrison; Jennifer Frye; Grace Davis-Gorman; Janet Funk; Paul McDonagh; Gregory Stahl; Leslie Ritter
Journal:  Curr Neurovasc Res       Date:  2011-02       Impact factor: 1.990

6.  Mild hypothermia inhibits systemic and cerebral complement activation in a swine model of cardiac arrest.

Authors:  Ping Gong; Hong Zhao; Rong Hua; Mingyue Zhang; Ziren Tang; Xue Mei; Juan Cui; Chunsheng Li
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-11       Impact factor: 6.200

Review 7.  Communication in the heart: the role of the innate immune system in coordinating cellular responses to ischemic injury.

Authors:  Slava Epelman; Douglas L Mann
Journal:  J Cardiovasc Transl Res       Date:  2012-10-05       Impact factor: 4.132

8.  Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death.

Authors:  Thiruma V Arumugam; Sung-Chun Tang; Justin D Lathia; Aiwu Cheng; Mohamed R Mughal; Srinivasulu Chigurupati; Tim Magnus; Sic L Chan; Dong-Gyu Jo; Xin Ouyang; David P Fairlie; Daniel N Granger; Alexander Vortmeyer; Milan Basta; Mark P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-21       Impact factor: 11.205

9.  Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage.

Authors:  M Fung; M Lu; H Fure; W Sun; C Sun; N Y Shi; Y Dou; J Su; X Swanson; T E Mollnes
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

10.  Human monocyte-derived dendritic cells are chemoattracted to C3a after up-regulation of the C3a receptor with interferons.

Authors:  Ralf Gutzmer; Margarete Lisewski; Jörg Zwirner; Susanne Mommert; Carola Diesel; Miriam Wittmann; Alexander Kapp; Thomas Werfel
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.